PARTNERSHIP: Healcloud announces partnership with Medexprim to optimize patient identification for research
PARTNERSHIP: Healcloud announces partnership with Medexprim to optimize patient identification for research
June 21st, 2021, by Healcloud
We are proud to announce that Healcloud has signed a strategic partnership with Medexprim, dedicated to the analysis of clinical data for patient identification.
Healcloud, a leading European technology enabler for life sciences research provides enterprise software to hospitals, clinical research organizations, and pharmaceutical companies, who would like to build virtual data networks that aggregate health Big Data with one tool to support clinical trials, observational studies, population health analytics, and pandemic monitoring.
Medexprim, the European expert in generating regulatory-grade datasets of aggregated images and clinical data, builds bridges between hospitals and pharmaceutical companies to accelerate clinical research, and pioneer new ways to design and execute clinical trials to dramatically reduce the associated time, cost, and risks.
This collaboration will expand both companies’ networks of hospitals, bring value to European hospitals and strengthen their research ecosystem. It will allow to answer pharmaceutical companies’ needs for patient identification for clinical trial.
We are very happy to announce our partnership with Healcloud, whose expertise is perfectly complementary with our ability to deliver complex homogeneous regulatory-grade datasets composed of clinical data, images, biology and genomics. Our collaboration will enable more European university hospitals to leverage their Real-World data in the service of clinical research and the well-being of patients.
By forging this strategic partnership with Medexprim, we empower both of our organizations to better fulfill the needs of our clients in pharmaceutical and life sciences research by offering a more comprehensive portfolio of services, a broader mix of GDPR-compliant data, including rich structured and unstructured clinical data complemented by imaging, as well as additional clinical site coverage across Europe. We look forward to collaborating with our colleagues at Medexprim, adding significant value to our clients and clinical research partners.
June 21st, 2021, by Healcloud
We are proud to announce that Healcloud has signed a strategic partnership with Medexprim, dedicated to the analysis of clinical data for patient identification.
Healcloud, a leading European technology enabler for life sciences research provides enterprise software to hospitals, clinical research organizations, and pharmaceutical companies, who would like to build virtual data networks that aggregate health Big Data with one tool to support clinical trials, observational studies, population health analytics, and pandemic monitoring.
Medexprim, the European expert in generating regulatory-grade datasets of aggregated images and clinical data, builds bridges between hospitals and pharmaceutical companies to accelerate clinical research, and pioneer new ways to design and execute clinical trials to dramatically reduce the associated time, cost, and risks.
This collaboration will expand both companies’ networks of hospitals, bring value to European hospitals and strengthen their research ecosystem. It will allow to answer pharmaceutical companies’ needs for patient identification for clinical trial.
We are very happy to announce our partnership with Healcloud, whose expertise is perfectly complementary with our ability to deliver complex homogeneous regulatory-grade datasets composed of clinical data, images, biology and genomics. Our collaboration will enable more European university hospitals to leverage their Real-World data in the service of clinical research and the well-being of patients.
By forging this strategic partnership with Medexprim, we empower both of our organizations to better fulfill the needs of our clients in pharmaceutical and life sciences research by offering a more comprehensive portfolio of services, a broader mix of GDPR-compliant data, including rich structured and unstructured clinical data complemented by imaging, as well as additional clinical site coverage across Europe. We look forward to collaborating with our colleagues at Medexprim, adding significant value to our clients and clinical research partners.